Due to increasing costs of healthcare, people are turning towards dietary supplements to help them stay healthy.

New York, United States – September 16, 2015 /MarketersMedia/ —

According to a new market report published by Persistence Market Research “Global Market Study on Dietary Supplements: Botanical Supplements To Be The Largest Market by 2020,” the global dietary supplements market was valued at USD 109.8 billion in 2013 and is expected to grow at a CAGR of 7.4% from 2014 to 2020, to reach an estimated value of USD 179.8 billion in 2020.

A growing interest in a healthy lifestyle is leading to an increase in the consumption of healthy food. Dietary supplements are the best choice for consumers looking to adopt a healthy lifestyle. People across various age groups consume dietary supplements to meet their recommended dietary allowances. Dietary supplements are available in different forms, such tablets, pills, powders, capsules, gelcaps, and liquids. Dietary supplements such as vitamin, botanical, mineral and fatty acid help consumers stay healthy and prevent nutritional deficiency diseases. Rising aging population, increasing lifestyle diseases and increasing healthcare cost are some of the important factors driving the growth of the dietary supplements market.

Download Sample Report: http://www.persistencemarketresearch.com/samples/2801

Asia-Pacific is the largest market for dietary supplements globally. Consumer awareness about the benefits of dietary supplements and wide product availability are the major drivers for the market in Asia Pacific. The increase in disposable income allows customers to spend more on healthy food items. According to the National Bureau of Statistics of China, annual per capita disposable income of urban households in China increased from USD 2,271.0 in 2008 to USD 3408.5 in 2012. The overall annual disposable income in India increased from USD 1,366.2 billion in 2010 to USD 1,587.6 billion in 2013.

The dietary supplements market in North America is at mature stage compared to that in developing nations in Asia and Africa. In recent years, consumers have become more conscious of their diet. According to a survey conducted by the Council for Responsible Nutrition (CRN) in 2014, around 68% of adults in the U.S. use dietary supplements; of these, around 50% are regular users. Rising number of elderly people in North America is leading to a rise in demand for dietary supplements products. Over the last few years, the risk of chronic diseases and maintenance of health in old age have been the major health concerns leading to increased spending on dietary supplement products. According to the U.S. Census Bureau, in 2012, 40 million people in the country are aged 65 and above. Europe is the second-largest market for dietary supplement products. Recently, consumers in the region are showing great interest in leading healthy lifestyles, in turn, driving the consumption of healthy food. In the European region, Western Europe is the largest market for dietary supplements. Eastern Europe is considered to have higher future growth potential. Rising aging population, increasing lifestyle diseases, and growing healthcare costs are some of the important factors driving the growth of the dietary supplements market in the region.

The dietary supplements market is bifurcated into product (vitamin, botanical, mineral, fatty acids, and others supplements) by value (USD billion), application (food and beverages, pharmaceuticals, personal care, and others) by value (USD billion), and end user (adult women, adult men, senior citizens, and others) by value (USD billion).

Global dietary supplements market grew from USD 90.6 billion in 2010 to USD 109.8 billion in 2013 at a CAGR of 6.6%. Under regional segment, the Asia-Pacific dietary supplements market ( the largest market in 2013) increased by 8.2% CAGR during 2010-2013 to reach USD 34.2 billion in 2013.

Browse the full report TOC at http://www.persistencemarketresearch.com/market-research/dietary-supplements-market.asp

Some of the major companies operating in the global dietary supplements market are NBTY, Inc., Koninklijke DSM N.V., Amway, Herbalife Ltd., Omega Protein Corporation, Bayer AG, Naturalife Asia Co., Ltd., Integrated BioPharma, Inc., Nu Skin Enterprises, Inc., BASF SE, Surya Herbal Ltd., Bio-Botanica Inc., The Himalaya Drug Company, Ricola AG, Pharmavite LLC, Blackmores Ltd., Epax AS, and Axellus AS.

Food and Beverages Market Research Reports: http://www.persistencemarketresearch.com/category/food-and-beverages.asp

About Us:

Persistence Market Research (PMR) is an innovative provider of market research reports and consulting services. The three PMR pillars of strength that have helped us win clients for years are: Quality Research, Quick Research, and In-depth Research.

PMR’s team of seasoned analysts and consultants are experts in their domain. At PMR, we process complex, exhaustive primary and secondary research data into valuable insight. We understand that each client has a unique problem statement, and address it with our strengths.

For more information about us, please visit http://www.persistencemarketresearch.com/

Contact Info:
Name: Glen Hare
Organization: Persistence Market Research PVT. LTD.
Address: 305 Broadway, 7th floor, New York, NY, United States, 10007
Phone: 16465687751

Source: http://marketersmedia.com/global-dietary-supplements-market-to-reach-us-179-8-billion-by-2020-persistence-market-research/91459

Release ID: 91459

The electronic commerce (e-commerce) industry is growing at a fast pace globally, which, consequentially, is leading to increasing in demand for corrugated packaging.

New York, United States – September 16, 2015 /MarketersMedia/ —

According to a new market report published by Persistence Market Research “Global Market Study on Corrugated Packaging: Glassware and ceramics application to witness highest growth by 2020”, the global corrugated packaging market is expected to grow at a CAGR of 4.0% during 2014 to 2020, to reach an estimated USD 173.6 million by 2020.

The corrugated packaging market is thriving mainly due to growing end-user industries, including food, medicine, consumer durables, rubber, and petroleum. Benefits associated with corrugated packagings such as sustainability and low cost makes it one of the preferred modes of packaging across various industries. Emerging markets offer tremendous growth opportunities for the corrugated packaging market due to increasing population and growing demand for consumer products in these regions. The e-commerce industry has emerged as one of the key drivers for the global corrugated packaging market. This is primary because the corrugated packaging is the most reliable form of packaging products in this industry.

Download Sample Report: http://www.persistencemarketresearch.com/samples/4433

However, certain restraints such as low endurance of corrugated packaging and stalled growth across certain end-user industries are affecting market growth. The market, in terms of competitive structure, is consolidated through large numbers of mergers and acquisitions. This indicates tough sustainability in this market.

Increasing population coupled with rising per capita income is encouraging industrial production worldwide, which, consequently, is increasing the number of shipments. Owing to low costs and easy handling, the corrugated packaging is considered as ideal for shipments across several industries. Based on the application, the corrugated packaging is used in different shapes such as sheets, liner board, boxes, and containerboards. Based on dimensions of the packaging medium, the corrugated packaging is classified as A-flute, B-flute, C-flute, E-flute, and F-flute.

The various application industries that use corrugated packaging include processed food, fresh food and produce, beverages, personal and household care, chemicals, paper products, electrical and electronic goods, glassware and ceramics, and tobacco.

Rising population and growing demand for food, medicine, and consumer durable goods in developing countries are driving the demand for packaging products in these regions. Low costs and high benefits of corrugated packaging have made them one of the most preferred packaging solutions across an array of industries in these regions. Food and healthcare are among the fastest growing industries in China that use corrugated packaging. The processed food sector in China is growing at a rate of over 10%. Electrical equipment and machinery (a key end-user for the corrugated packaging market) market in China is growing at over 11%. Indonesia is another emerging economy with a large number of food processing companies. This, in turn, is driving the corrugated packaging market.

China, Japan, India, and Indonesia are the major corrugated packaging material producers in Asia Pacific. The U.S. leads the corrugated packaging material production in North America while the European market is dominated by Italy, France, Germany, Spain, the U.K., and Poland. Brazil and Turkey feature among the leading corrugated packaging material producers in Rest of the World (RoW).

View full report TOC at http://www.persistencemarketresearch.com/market-research/corrugated-packaging-market.asp

Major companies in the corrugated packaging market include International Paper Company, Nine Dragons Paper (Holdings) Limited, Rock-Tenn Company, Smurfit Kappa Group, Lee & Man Paper Manufacturing Ltd., Georgia-Pacific Equity Holdings LLC, Oji Holdings Corporation, Mondi Group, Packaging Corporation of America, and DS Smith Plc.

Chemicals and Materials Market Research Reports: http://www.persistencemarketresearch.com/category/chemicals-and-materials.asp

About

Persistence Market Research (PMR) is an innovative provider of market research reports and consulting services. The three PMR pillars of strength that have helped us win clients for years are: Quality Research, Quick Research, and In-depth Research.

PMR’s team of seasoned analysts and consultants are experts in their domain. At PMR, we process complex, exhaustive primary and secondary research data into valuable insight. We understand that each client has a unique problem statement, and address it with our strengths.

For more information about us, please visit http://www.persistencemarketresearch.com/

Contact Info:
Name: Glen Hare
Email: glen@persistencemarketresearch.com
Organization: Persistence Market Research PVT. LTD.
Address: 305 Broadway, 7th floor, New York, NY, United States, 10007
Phone: 16465687751

Source: http://marketersmedia.com/global-corrugated-packaging-market-to-reach-us-173-6-million-by-2020-persistence-market-research/91461

Release ID: 91461

Various factors such as increasing chronic diseases, aging population, and technological advancements in biopharmaceuticals along with increasing investment in research and development by various companies has lead to the growth of the global biopharmaceuticals market.

New York, United States – September 16, 2015 /MarketersMedia/ —

According to a new market report published by Persistence Market Research “Global Market Study on Biopharmaceuticals: Asia to Witness Highest Growth by 2020”, the global biopharmaceuticals market was valued at US$ 162 Bn in 2014 and is expected to grow at a CAGR of 9.4% from 2014 to 2020, to reach an estimated value of US$ 278 Bn by 2020.

View Sample Report: http://www.persistencemarketresearch.com/samples/2827

Biopharmaceuticals are medicinal drugs, produced by isolation of the medicinal products from biological sources such as from animals, plants, humans and microorganisms, using biotechnological techniques such as recombinant DNA technology. They can also be produced using transgenic organisms, particularly animals and plants that have been genetically engineered to produce drugs. These drugs help in prevention and treatment of various diseases such as rheumatoid arthritis, psoriatic arthritis, psoriasis, cardiovascular disease, anemia arising from chemotherapy, chronic renal failure, cancer, and diabetes.

Globally, the biopharmaceuticals market is witnessing significant growth due to increasing prevalence of chronic diseases, rising aging population, technological advancements in biopharmaceuticals, and increasing R&D investments. In addition, the capability of biopharmaceuticals to approach a particular target with high efficacy helps in the treatment of various chronic diseases and disorders. Biopharmaceuticals, such as monoclonal antibodies, hormones, cytokines, clotting factors, cell therapies, antisense drugs, recombinant insulin, and vaccines, have the potential to prevent, treat, and completely heal the diseases which are otherwise difficult to cure or have no available treatment. This, in turn, fuels growth of the biopharmaceuticals market. However, factors such as high costs of biopharmaceuticals, the risk of side–effects, and availability of low-cost biosimilars are restraining the growth of the global market for biopharmaceuticals. The global biopharmaceuticals market was valued at US$ 162 Bn in 2014 and is expected to reach US$ 278 Bn by 2020 at a CAGR of 9.4% during the forecast period.

North America is the largest market for biopharmaceuticals. This is due to technological advancements in the region. The North America market for biopharmaceuticals was valued at US$ 64.7 Bn in 2014 and is expected to reach US$ 111.5 Bn by 2020 at a CAGR of 9.5% over the forecast period. In terms of type, monoclonal antibodies are the fastest growing segment. In terms of therapeutic application, oncology is the largest segment in the biopharmaceuticals market. Biopharmaceuticals have wide applications in the pharmaceutical industry.

One of the latest trends in the global biopharmaceuticals market is that of outsourcing, where biopharmaceutical companies are dependent on contract manufacturing organizations to produce a biopharmaceutical drug substance, which helps reducing investments for a new product launch.

Browse the full report toc at http://www.persistencemarketresearch.com/market-research/biopharmaceutical-market.asp

Pfizer, Inc., F. Hoffmann-La Roche AG, Johnson & Johnson Services, Inc., Sanofi, Amgen Inc., AbbVie Inc., Merck & Co., Inc., Biogen Idec, Bayer AG, Eli Lilly and Company, and Novartis AG are leading players in the global biopharmaceuticals market. Some of the other players in the biopharmaceuticals market are GlaxoSmithKline Plc, Bristol-Myers Squibb Company, AstraZeneca PLC, and Abbott Laboratories.

Pharmaceuticals Market Research Reports: http://www.persistencemarketresearch.com/category/pharmaceuticals.asp

About Us

Persistence Market Research (PMR) is a U.S.-based full-service market intelligence firm specializing in syndicated research, custom research, and consulting services. PMR boasts market research expertise across the Healthcare, Chemicals and Materials, Technology and Media, Energy and Mining, Food and Beverages, Semiconductor and Electronics, Consumer Goods, and Shipping and Transportation industries. The company draws from its multi-disciplinary capabilities and a high-pedigree team of analysts to share data that precisely corresponds to clients’ business needs.

PMR stands committed to bringing more accuracy and speed to clients’ business decisions. From ready-to-purchase market research reports to customized research solutions, PMR’s engagement models are highly flexible without compromising on its deep-seated research values.

For more information about us, please visit http://www.persistencemarketresearch.com/

Contact Info:
Name: Glen Hare
Organization: Persistence Market Research PVT. LTD.
Address: 305 Broadway, 7th floor, New York, NY, United States, 10007
Phone: 16465687751

Source: http://marketersmedia.com/global-biopharmaceuticals-market-to-reach-us-278-billion-by-2020-persistence-market-research/91455

Release ID: 91455

Princeview Dental, one of Etobicoke’s premier dental clinics, is alerting dental patients about the importance of providing their dentists with an updated medication profile to avoid adverse drug interactions.

Toronto, Canada – September 16, 2015 /MarketersMedia/ —

Princeview Dental (www.PrinceviewDental.com), a dedicated family dental practice in Etobicoke, is alerting dental patients about the importance of providing their dentists with an updated medication profile to avoid adverse drug interactions.

The importance of patient-dentist communication concerning medication disclosure was highlighted in a recent study published in the Journal of the Canadian Dental Association (JCDA). According to the study, roughly two-thirds of dental patients are taking some form of prescription, over-the-counter medicine or vitamin supplement. Study authors suggest that it is essential patients give this information to their dental practitioners.
(Source: “Fitzgerald, J., et al., “Outpatient Medication Use and Implications for Dental Care: Guidance for Contemporary Dental Practice,” Journal of the Canadian Dental Association web site, July 7, 2015; http://www.jcda.ca/article/f10/.)

“There is a very real risk that an adverse drug interaction can occur if patients aren’t properly self-reporting their medications,” says Dr. Janice Mummery, founder of Princeview Dental. “A number of different drugs can be prescribed at a dental office. This could potentially be problematic if a dental practitioner doesn’t have the same access to the patient’s health records that is present in a medical office or hospital.”

According to Dr. Mummery, one of the common vasoconstrictor drugs used in oral surgery can potentially cause a hypertensive episode when it interacts with certain antidepressants. Similarly, anyone who is taking drugs that affects their blood pressure, even something as seemingly innocent as “Aspirin”, could experience unexpected excessive bleeding.

“These are avoidable events provided the patient self-reports accurately. Even if it doesn’t seem relevant, it should be mentioned,” Dr. Mummery emphasizes. “Some medications have side effects, like dry mouth. For a dentist, that is important information to have since knowledge of a patient’s oral environment is necessary for proper duty of care.”

Princeview Dental has been a fixture of the Kingsway area in Etobicoke for over 20 years and is a leading provider of dedicated family dental services. Visit the Princeview Dental web site at http://www.princeviewdental.com to book an appointment or call Princeview Dental at 416-231-4562.

For more information about us, please visit http://www.princeviewdental.com/

Contact Info:
Name: Dr. Janice Mummery
Organization: Princeview Dental
Address: 2943 Bloor Street West Etobicoke, Ontario M8X 1B3
Phone: (416) 231 4562

Source: http://marketersmedia.com/princeview-dental-encourages-medication-disclosure-to-dentists/91457

Release ID: 91457

The Canadian Institute of Hair and Scalp Specialists comments on the awareness of female pattern hair loss.

Mississauga, Canada – September 16, 2015 /MarketersMedia/ —

The Canadian Institute of Hair and Scalp Specialists (www.CanadianHair.ca), a Toronto-based organization offering hair loss treatment for over 25 years, is weighing in on the increased need for awareness about female pattern hair loss.

Androgenic alopecia, or female pattern hair loss, is the most common cause of hair loss in women. Unlike in men, women experiencing androgenic alopecia notice their hair thinning around the part rather than having a receding hairline. The condition is largely genetic, with a suspected link to the hormone androgen. It can occur as early as age 20, though it is more common in the 40s. (Source: Leap, A., “When thin is not in: Hair loss for women has multiple causes, needs correct diagnosis,” Pocono Record web site, September 9, 2015; http://www.poconorecord.com/article/20150909/ENTERTAINMENTLIFE/150909461.)

“It can be a distressing situation, especially since current culture places a lot of emphasis on a woman’s hair.” says Ken Robson, Founder of the Canadian Institute of Hair and Scalp Specialists. “In rare cases, it can even progress to full baldness.”

Hair loss can be a great source of social and personal anxiety for women and can negatively affect their self-esteem. Compounding matters is that there is no known preventative treatment; the only approved remedy, the drug minoxidil, also only works in about 20% of cases.

“However, here are other options if minoxidil fails,” Robson adds. “Depending on how far the condition has progressed, it can be hidden with an alternate hair style. However, the most effective means is currently a hair transplant.”

Hair transplant procedures replace the deactivated hair follicles with live ones from elsewhere on the body. It is a permanent procedure with established effectiveness.

“It’s important not only that women are aware that hair loss isn’t just an issue for men, but that they know there are options available for them as well,” Robson concludes. “Those suffering from hair loss should always consult for a doctor or dermatologist to determine the cause and what the possible treatments are.”

For more information on the Canadian Institute of Hair and Scalp Specialists and their available treatment options, visit www.CanadianHair.ca or call 905-272-0190.

For more information about us, please visit http://canadianhair.ca/

Contact Info:
Name: Ken Robson
Organization: The Canadian Institute of Hair & Scalp Specialists
Address: 89 Queensway West Suite 310 Mississauga, Ontario L5B 2V2 Canada
Phone: 905-272-0190

Source: http://marketersmedia.com/the-canadian-institute-of-hair-and-scalp-specialists-weighs-in-on-female-pattern-hair-loss-awareness/91411

Release ID: 91411

Revolutionary Brands Inc. weighs in on research that reveals that an excess of vitamin B12 may lead to acne outbreaks.

Stouffville, Canada – September 16, 2015 /MarketersMedia/ —

Revolutionary Brands Inc. (www.RevBrandsInc.com), a seller and distributor of unique products throughout North America, is responding to a study linking an excess of vitamin B12 to skin conditions such as acne.
According to a study from the University of California, Los Angeles, individuals with high levels of vitamin B12 may be more susceptible to acne than others. The researchers, in an effort to determine what makes certain people more likely to develop acne, found indicators that vitamin B12 may play a role by disrupting a skin bacteria known as Propionibacterium acnes. From there, they had 10 people with clear skin start taking vitamin B12. However, despite the extra consumption of the vitamin affecting how the genes in skin bacteria processed it, only one subject developed acne. (Source: Dotinga, R., “Could a Vitamin Play a Role in Acne Outbreaks?” WebMD, June 24, 2015; http://www.webmd.com/skin-problems-and-treatments/acne/news/20150624/could-a-vitamin-play-a-role-in-acne-outbreaks.)

“Even though this study’s findings are preliminary, it does give hope to those suffering from acne and other skin blemishes,” says Brett Lawson, owner of Revolutionary Brands Inc. “This means that researchers will potentially be able to develop medicine that can be used to clear acne.”

It’s still unclear why only one test subject developed acne and the researchers hope that further study will lead to an understanding of why certain people are predisposed to acne if their body contains too much vitamin B12. The study also found that certain genes could possibly influence acne development, which will also require further research.

“This doesn’t mean that people who are suffering from acne breakouts should stop taking B12 supplements or stop consuming foods that contain the vitamin, such as dairy and shellfish” Lawson concludes. “Those who ingest a lot of vitamin B12 or take supplements and notice skin blemishes should consider cutting back. And if an outbreak has already occurred, an acne cream cream can help to clear it up.”

Revolutionary Brands Inc.’s Nova C60 line offers creams to remove blemishes. The ingredients include salicylic acid and the Nobel Prize-winning fullerene, two compounds effective for fighting acne and other skin blemishes. For more information, visit www.RevBrandsInc.com.

For more information about us, please visit http://www.novac60.com

Contact Info:
Name: Brad Lawson
Organization: Revolutionary Brands Inc
Phone: (905) 251-5450

Source: http://marketersmedia.com/revolutionary-brands-inc-responds-to-study-that-reveals-link-between-vitamin-b12-excess-and-skin-conditions/91413

Release ID: 91413